Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
4
57%
Ph not_applicable
1
14%
Ph phase_2
1
14%
Ph phase_3
1
14%

Phase Distribution

0

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
4(57.1%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(4)
Other(3)

Detailed Status

Completed4
unknown3

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (14.3%)
Phase 31 (14.3%)
Phase 44 (57.1%)
N/A1 (14.3%)

Trials by Status

unknown343%
completed457%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_4

Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity Study

NCT03722004
unknownnot_applicable

Use of mOPV1 in Routine Immunization in Pakistan.

NCT04504539
completedphase_4

Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV

NCT03310073
unknownphase_3

Assessment of Community Transmission of Sabin Type 2 Virus in Bangladesh

NCT02477046
completedphase_4

Polio End-game Strategies - Poliovirus Type 2 Challenge Study

NCT02189811
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT03722004Phase 4

Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity Study

Completed
NCT04504539Not Applicable

Use of mOPV1 in Routine Immunization in Pakistan.

Unknown
NCT03310073Phase 4

Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV

Completed
NCT02477046Phase 3

Assessment of Community Transmission of Sabin Type 2 Virus in Bangladesh

Unknown
NCT02189811Phase 4

Polio End-game Strategies - Poliovirus Type 2 Challenge Study

Completed
NCT02111135Phase 2

Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life

Completed
NCT01841671Phase 4

Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine

Unknown

All 7 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
7